meddevicedb.com FDA Device Reference

URINE COCAINE METABOLITE SCREEN FLEX REAGENT CARTRIDGE, CATALOG# DF92A

K033713 Class II Traditional
Decision Date
2004-02-09
Sponsor / Applicant
Dade Behring, Inc.

Technical Specification

510(k) Submission ID K033713
Product Code DIO
Medical Specialty / Panel Clinical Toxicology
Regulation Citation 21 CFR 862.3250
Decision Date 2004-02-09
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

URINE COCAINE METABOLITE SCREEN FLEX REAGENT CARTRIDGE, CATALOG# DF92A received FDA 510(k) clearance under submission number K033713, sponsored by Dade Behring, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Toxicology review panel. The statutory decision date of record is 2004-02-09.

Classification & Regulation

This clearance is catalogued under FDA product code DIO and 21 CFR 862.3250, within the Clinical Toxicology review panel as a Class II device.